Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 11:27 am Sale | 2025-09-30 | 13G | Stoke Therapeutics, Inc. STOK | Cowen Financial Products LLC | 0 0.000% | -3,173,258 (Position Closed) | Filing History |
| 2025-11-14 11:24 am Purchase | 2025-09-30 | 13G | Stoke Therapeutics, Inc. STOK | The Toronto-Dominion Bank | 3,173,258 5.800% | 3,173,258 (New Position) | Filing History |
| 2025-11-05 11:49 am Sale | 2025-09-30 | 13G | Stoke Therapeutics, Inc. STOK | FMR LLC | 6,865,057 12.500% | -547,925 (-7.39%) | Filing History |
| 2025-10-17 6:24 pm Purchase | 2025-09-30 | 13G | Stoke Therapeutics, Inc. STOK | BlackRock Inc. BLK | 3,732,540 6.800% | 613,606 (+19.67%) | Filing History |
| 2025-08-26 5:42 pm Sale | 2025-08-22 | 13D | Stoke Therapeutics, Inc. STOK | Skorpios Trust | 2,256,181 4.100% | -1,000,000 (-30.71%) | Filing History |
| 2025-08-14 4:19 pm Sale | 2025-06-30 | 13G | Stoke Therapeutics, Inc. STOK | Redmile Group, LLC | 4,375,931 8.000% | -337,578 (-7.16%) | Filing History |
| 2025-08-06 12:14 pm Purchase | 2025-06-30 | 13G | Stoke Therapeutics, Inc. STOK | FMR LLC | 7,412,982 13.600% | 1,553,971 (+26.52%) | Filing History |
| 2025-07-29 5:11 pm Sale | 2025-06-30 | 13G | Stoke Therapeutics, Inc. STOK | Cowen Financial Products LLC | 3,173,258 5.800% | -548,401 (-14.74%) | Filing History |
| 2025-07-15 5:12 pm Sale | 2025-06-30 | 13G | Stoke Therapeutics, Inc. STOK | BlackRock Portfolio Management LLC | 2,550,341 4.700% | -193,161 (-7.04%) | Filing History |
| 2025-06-23 4:47 pm Sale | 2025-06-18 | 13D | Stoke Therapeutics, Inc. STOK | Skorpios Trust | 3,256,181 6.000% | -650,000 (-16.64%) | Filing History |
| 2025-06-06 4:23 pm Sale | 2025-06-04 | 13D | Stoke Therapeutics, Inc. STOK | Skorpios Trust | 3,906,181 7.200% | -3,000,000 (-43.44%) | Filing History |
| 2025-06-06 10:03 am Purchase | 2025-05-30 | 13G | Stoke Therapeutics, Inc. STOK | FMR LLC | 5,859,011 10.700% | 5,854,011 (+117080.22%) | Filing History |
| 2025-04-16 6:41 pm Sale | 2025-03-31 | 13G | Stoke Therapeutics, Inc. STOK | BlackRock Inc. BLK | 3,118,934 5.800% | -2,290,235 (-42.34%) | Filing History |
| 2025-04-15 5:04 pm Purchase | 2025-03-31 | 13G | Stoke Therapeutics, Inc. STOK | BlackRock Portfolio Management LLC | 2,743,502 5.100% | 2,743,502 (New Position) | Filing History |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW Investments, LP | 5,310,033 9.990% | 1,178,988 (+28.54%) | Filing History |
| 2025-02-03 4:36 pm Purchase | 2024-12-31 | 13G | Stoke Therapeutics, Inc. STOK | MORGAN STANLEY MS | 3,426,739 6.500% | 68,364 (+2.04%) | Filing History |
| 2024-12-27 5:23 pm Sale | 2024-12-23 | 13D | Stoke Therapeutics, Inc. STOK | Skorpios Trust | 6,906,181 13.000% | -2,000,000 (-22.46%) | Filing History |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | Stoke Therapeutics, Inc. STOK | Redmile Group, LLC | 4,713,509 9.000% | 2,088,003 (+79.53%) | Filing History |
| 2024-11-14 4:24 pm Purchase | 2024-09-30 | 13G | Stoke Therapeutics, Inc. STOK | BAKER BROS. ADVISORS LP | 4,368,443 8.300% | 4,368,443 (New Position) | Filing History |
| 2024-11-14 09:00 am Purchase | 2024-09-30 | 13G | Stoke Therapeutics, Inc. STOK | Lynx1 Capital Management LP | 5,187,191 9.900% | 2,230,273 (+75.43%) | Filing History |